Simone Sredni

New potential treatment for aggressive brain cancer in children

Using state-of-the-art gene editing technology, scientists have discovered a promising…

12 April 2017 | By Niamh Marriott (Drug Target Review)

Using state-of-the-art gene editing technology, scientists have discovered a promising target to treat atypical teratoid/rhabdoid tumour (AT/RT) - a highly aggressive and therapy resistant brain tumour that mostly occurs in infants.